|
| |
| | | 68628 | | 12.12.2023 | | Sandoz Pharmaceuticals AG | | | | | | | 11.12.2028 | | | | | | 01.06. | | | | 01.06. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Bupropion XR Sandoz 150 mg | Retardtabletten | Retard-Tabletten (Bupropion Hydrochlorid 150 mg) | N06AX12 | PI | | 02 | Bupropion XR Sandoz 300 mg | Retardtabletten | Retard-Tabletten (Bupropion Hydrochlorid 300 mg) | N06AX12 | |
|
|
|
